Crossmark

Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: a retrospective study

Crossref DOI link: https://doi.org/10.1186/s12885-018-4691-0

Published Online: 2018-07-28

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, In Ae

Lee, Jong Sik

Kim, Hee Joung

Kim, Wan Seop

Lee, Kye Young https://orcid.org/0000-0003-4687-5593
License Information

Text and Data Mining valid from 2018-07-28
More Information

Article History

Received: 26 February 2018

Accepted: 24 July 2018

First Online: 28 July 2018

Ethics approval and consent to participate

: The study protocol was approved by the Konkuk Medical University Hospital Institutional Review Board (Approval number: KUH1010901), and the need for written informed consent from the participants was waived due to the retrospective nature of this study. It was conducted in accordance with the amended Declaration of Helsinki.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.